Literature DB >> 11870941

Catheter therapy of Swiss cheese ventricular septal defects using the Amplatzer muscular VSD occluder.

David J Waight1, Emile A Bacha, Madelyn Kahana, Qi-Ling Cao, Mary Heitschmidt, Ziyad M Hijazi.   

Abstract

The medical and surgical management of patients with multiple muscular ventricular septal defects (VSDs) is associated with morbidity and mortality. Three children with Swiss cheese VSDs were treated with transcatheter occlusion of their multiple defects using the Amplatzer muscular VSD occluder. Seventeen defects were closed in five catheterization procedures. One patient had three devices placed in two procedures, the second had five defects closed in one procedure, and the third had nine defects closed in two procedures. Two patients had previously been treated with pulmonary artery banding and required subsequent surgical band removal. There was immediate reduction in the left-to-right shunting and clinical improvement in all patients. Complications included the need for blood transfusion during the two longest procedures and tricuspid valve regurgitation in one. Transcatheter occlusion of multiple VSDs is an acceptable alternative or adjunct to surgical therapy for these complex patients. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11870941     DOI: 10.1002/ccd.10124

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  11 in total

1.  Hybrid pediatric cardiac surgery.

Authors:  E A Bacha; Z M Hijazi; Q-L Cao; R Abdulla; J P Starr; J Quinones; P Koenig; B Agarwala
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

2.  Successful occlusion of a persistent left vertical vein with an Amplatzer muscular ventricular septal defect occluder.

Authors:  Albrecht Beitzke; Andreas Gamillscheg; Martin Koestenberger
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460

Review 3.  Current topics in surgery for multiple ventricular septal defects.

Authors:  Naoki Yoshimura; Kazuaki Fukahara; Akio Yamashita; Yoshinori Doki; Katsunori Takeuchi; Tomonori Higuma; Kazutaka Senda; Masayoshi Toge; Tatsuro Matsuo; Saori Nagura; Masaya Aoki; Kimimasa Sakata; Mari Sakai
Journal:  Surg Today       Date:  2015-05-03       Impact factor: 2.549

4.  Percutaneous Closure of Perimembranous Ventricular Septal Defect with Amplatzer Device.

Authors:  P Bharadwaj; A Banerji; R Datta; H Singh; A K Ghosh; G Keshavamurthy
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder.

Authors:  B D Thanopoulos; M L Rigby
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

6.  Multicenter experience with perventricular device closure of muscular ventricular septal defects.

Authors:  E A Bacha; Q L Cao; M E Galantowicz; J P Cheatham; C E Fleishman; S W Weinstein; P A Becker; S L Hill; P Koenig; E Alboliras; R Abdulla; J P Starr; Z M Hijazi
Journal:  Pediatr Cardiol       Date:  2005 Mar-Apr       Impact factor: 1.655

7.  Percutaneous Ventricular Septal Defect Closure in Patients Under 1 Year of Age.

Authors:  Nazmi Narin; Ozge Pamukcu; Aydin Tuncay; Ali Baykan; Suleyman Sunkak; Onur Tasci; Kazim Uzum; Levent Saltık
Journal:  Pediatr Cardiol       Date:  2018-03-15       Impact factor: 1.655

8.  Perventricular device closure of isolated muscular ventricular septal defect in infants: a single centre experience.

Authors:  Bhavesh Thakkar; Nehal Patel; Shaunak Shah; Vishal Poptani; Tarun Madan; Chirag Shah; Anand Shukla; Vaishali Prajapati
Journal:  Indian Heart J       Date:  2012-09-12

Review 9.  MicroRNAs in congenital heart disease.

Authors:  Tanya Smith; Cha Rajakaruna; Massimo Caputo; Costanza Emanueli
Journal:  Ann Transl Med       Date:  2015-12

10.  Hybrid approach for closure of muscular ventricular septal defects.

Authors:  Ireneusz Haponiuk; Maciej Chojnicki; Radoslaw Jaworski; Mariusz Steffek; Jacek Juscinski; Mariusz Sroka; Roland Fiszer; Aneta Sendrowska; Katarzyna Gierat-Haponiuk; Bohdan Maruszewski
Journal:  Med Sci Monit       Date:  2013-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.